Since 2013, the ITOMIC triple negative breast cancer trial has been on the leading edge of where cancer advances are going... equipping physicians and patients with personalized information about how to treat their cancer. To date, 31 patients have been enrolled in the trial, 28 of whom are South Sound CARE patients. The ITOMIC trial has opened up an avenue for this innovative approach for patients with an incurable form of breast cancer. The study is getting international attention in scientific articles... and now in the New York Times.
Related Articles
Our team is the heart and soul of our organization! We consider ourselves incredibly fortunate to have the most exceptional team members in the...
At The Rush Companies, we celebrate individuals whose commitment to our values—Commitment, Resourcefulness, Integrity, and Well-Being—shines through...
At Rush, we believe in giving back to the communities we live and work in. With combined efforts from The Rush Gives Committee, Rush Corporate, and...